Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) (SLSII)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by University of California, Los Angeles.
Recruitment status was  Active, not recruiting
National Heart, Lung, and Blood Institute (NHLBI)
Hoffmann-La Roche
Information provided by (Responsible Party):
Philip Clements, University of California, Los Angeles Identifier:
First received: April 16, 2009
Last updated: April 20, 2013
Last verified: September 2009
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)